Platomics and biocrates announce strategic collaboration: A Game-Changer for the adoption of metabolomics 

Innsbruck and Vienna, Austria, March 11, 2025 – biocrates life sciences AG, a global leader in quantitative metabolomics, and regulatory automation provider Platomics announce a strategic collaboration to support laboratories with ensuring and documenting the quality of their workflows with biocrates metabolomics solutions.

biocrates’ metabolomics kits—which can quantify up to hundreds of metabolites across key biological pathways—are registered on Platomics’ state-of-the-art digital regulatory PlatoX® platform and can be effortlessly incorporated into the technical documentation of laboratory workflows. This partnership contributes to ensuring highly reproducible quantitative results and comprehensive standardized documentation for workflows which are also faster in service—with less effort for labs. 

Structured files, integrated guidance and the regulatory knowledgebase on the PlatoX® platform make it easier for labs to follow relevant best practices and apply standards, and to appropriately document the quality of their workflows, from sample preparation to sophisticated data analysis. PlatoX® supports laboratories in optimizing their regulatory pathway, reducing operational complexity, and ensuring comprehensive documentation. 

“Partnering with Platomics is a pivotal step in our mission to make metabolomics accessible,” said Moritz Seuster, CEO of biocrates life sciences AG. “By bringing our kits onto the PlatoX® platform, we’re empowering laboratories to quickly adopt accurate quantitative metabolomics and document the quality of their work – ultimately leading to better results and more insights on every sample.” 

“Platomics provides infrastructure for the digitization and automation of regulatory processes, with structured documentation of best practices and applicable standards. The collaboration with biocrates furthers our commitment to providing labs with best-in-class automated tools for ensuring and documenting the quality of their lab work,” stated Dr. Albert Kriegner, CEO of Platomics GmbH. 

About biocrates life sciences AG 

Founded in 2002 and headquartered in Innsbruck, Austria, biocrates life sciences AG is a leading provider of targeted metabolomics solutions. The company’s products are trusted by top research institutions, pharmaceutical companies, and clinical laboratories around the world. biocrates is dedicated to advancing metabolomics through its high-quality, standardized kits, which enable the comprehensive analysis of metabolites in various biological systems. 

Contact biocrates life sciences AG 

Sebastian Gottfried, PhD 
Chief Marketing Officer 
Contact | Website

About Platomics GmbH 

Platomics automates regulatory processes and connects in vitro diagnostic manufacturers and laboratories to accelerate compliance and bring innovation to patients faster. The PlatoX® platform saves time, resources and costs for all stakeholders involved in IVDR compliance by digitalizing regulatory work on the basis of intelligent data, not docs. 

Contact Platomics 

Christina White, PhD 
Communications
Contact | Website

For more information contact us below or connect with us on LinkedIn